163 related articles for article (PubMed ID: 36826995)
21. Peripheral T-cell lymphoma with follicular T-cell markers.
Rodríguez-Pinilla SM; Atienza L; Murillo C; Pérez-Rodríguez A; Montes-Moreno S; Roncador G; Pérez-Seoane C; Domínguez P; Camacho FI; Piris MA
Am J Surg Pathol; 2008 Dec; 32(12):1787-99. PubMed ID: 18779728
[TBL] [Abstract][Full Text] [Related]
22. The inducible T-cell co-stimulator molecule is expressed on subsets of T cells and is a new marker of lymphomas of T follicular helper cell-derivation.
Marafioti T; Paterson JC; Ballabio E; Chott A; Natkunam Y; Rodriguez-Justo M; Plonquet A; Rodriguez-Pinilla SM; Klapper W; Hansmann ML; Pileri SA; Isaacson PG; Stein H; Piris MA; Mason DY; Gaulard P
Haematologica; 2010 Mar; 95(3):432-9. PubMed ID: 20207847
[TBL] [Abstract][Full Text] [Related]
23. T follicular helper phenotype predicts response to histone deacetylase inhibitors in relapsed/refractory peripheral T-cell lymphoma.
Ghione P; Faruque P; Mehta-Shah N; Seshan V; Ozkaya N; Bhaskar S; Yeung J; Spinner MA; Lunning M; Inghirami G; Moskowitz A; Galasso N; Ganesan N; van der Weyden C; Ruan J; Prince HM; Trotman J; Advani R; Dogan A; Horwitz S
Blood Adv; 2020 Oct; 4(19):4640-4647. PubMed ID: 33002132
[TBL] [Abstract][Full Text] [Related]
24. First-in-Human Phase I/II ICONIC Trial of the ICOS Agonist Vopratelimab Alone and with Nivolumab: ICOS-High CD4 T-Cell Populations and Predictors of Response.
Yap TA; Gainor JF; Callahan MK; Falchook GS; Pachynski RK; LoRusso P; Kummar S; Gibney GT; Burris HA; Tykodi SS; Rahma OE; Seiwert TY; Papadopoulos KP; Blum Murphy M; Park H; Hanson A; Hashambhoy-Ramsay Y; McGrath L; Hooper E; Xiao X; Cohen H; Fan M; Felitsky D; Hart C; McComb R; Brown K; Sepahi A; Jimenez J; Zhang W; Baeck J; Laken H; Murray R; Trehu E; Harvey CJ
Clin Cancer Res; 2022 Sep; 28(17):3695-3708. PubMed ID: 35511938
[TBL] [Abstract][Full Text] [Related]
25. CD10 and ICOS expression by multiparametric flow cytometry in angioimmunoblastic T-cell lymphoma.
Baseggio L; Traverse-Glehen A; Berger F; Ffrench M; Jallades L; Morel D; Goedert G; Magaud JP; Salles G; Felman P
Mod Pathol; 2011 Jul; 24(7):993-1003. PubMed ID: 21499231
[TBL] [Abstract][Full Text] [Related]
26. The Short-Term Efficacy and Safety of Brentuximab Vedotin Plus Cyclophosphamide, Epirubicin and Prednisone in Untreated PTCL: A Real-World, Retrospective Study.
Feng X; Guo W; Wang Y; Li J; Zhao Y; Qu L; Yan X; Li J; Guo Q; Young KH; Bai O
Adv Ther; 2022 Jan; 39(1):532-543. PubMed ID: 34797505
[TBL] [Abstract][Full Text] [Related]
27. Effects of ICOS+ T cell depletion via afucosylated monoclonal antibody MEDI-570 on pregnant cynomolgus monkeys and the developing offspring.
Nicholson SM; Carlesso G; Cheng LI; Cook H; DaCosta K; Leininger J; McKeever K; Scott SW; Taylor D; Streicher K; Eck S; Reed M; Faggioni R; Herbst R; Dixit R; Ryan PC
Reprod Toxicol; 2017 Dec; 74():116-133. PubMed ID: 28916434
[TBL] [Abstract][Full Text] [Related]
28. Comprehensive comparison of international prognostic indexes for follicular helper T-cell lymphoma.
Lee YP; Yoon SE; Cho J; Ko YH; Jo H; Kim SJ; Kim WS
Ann Hematol; 2022 Jul; 101(7):1535-1543. PubMed ID: 35639152
[TBL] [Abstract][Full Text] [Related]
29. Aberrant populations of circulating T follicular helper cells and regulatory B cells underlying idiopathic pulmonary fibrosis.
Asai Y; Chiba H; Nishikiori H; Kamekura R; Yabe H; Kondo S; Miyajima S; Shigehara K; Ichimiya S; Takahashi H
Respir Res; 2019 Nov; 20(1):244. PubMed ID: 31694639
[TBL] [Abstract][Full Text] [Related]
30. Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study.
Abramson JS; Palomba ML; Gordon LI; Lunning MA; Wang M; Arnason J; Mehta A; Purev E; Maloney DG; Andreadis C; Sehgal A; Solomon SR; Ghosh N; Albertson TM; Garcia J; Kostic A; Mallaney M; Ogasawara K; Newhall K; Kim Y; Li D; Siddiqi T
Lancet; 2020 Sep; 396(10254):839-852. PubMed ID: 32888407
[TBL] [Abstract][Full Text] [Related]
31. Follicular helper T-cells: expanding roles in T-cell lymphoma and targets for treatment.
Ahearne MJ; Allchin RL; Fox CP; Wagner SD
Br J Haematol; 2014 Aug; 166(3):326-35. PubMed ID: 24815671
[TBL] [Abstract][Full Text] [Related]
32. CCR9/CXCR5 Co-Expressing CD4 T Cells Are Increased in Primary Sjögren's Syndrome and Are Enriched in PD-1/ICOS-Expressing Effector T Cells.
Hinrichs AC; Kruize AA; Lafeber FPJG; Leavis HL; van Roon JAG
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569326
[TBL] [Abstract][Full Text] [Related]
33. A Clinicopathologic Study of Lennert Lymphoma and Possible Prognostic Factors: The Importance of Follicular Helper T-cell Markers and the Association With Angioimmunoblastic T-cell Lymphoma.
Kurita D; Miyoshi H; Yoshida N; Sasaki Y; Kato S; Niino D; Sugita Y; Hatta Y; Takei M; Makishima M; Ohshima K
Am J Surg Pathol; 2016 Sep; 40(9):1249-60. PubMed ID: 27428734
[TBL] [Abstract][Full Text] [Related]
34. Distinct phenotypic subpopulations of circulating CD4
Liu D; Liu J; Wang J; Liu C; Yang S; Jiang Y
BMC Immunol; 2016 Oct; 17(1):40. PubMed ID: 27769184
[TBL] [Abstract][Full Text] [Related]
35. Abnormal Shift in B Memory Cell Profile Is Associated With the Expansion of Circulating T Follicular Helper Cells
Lu X; Zhang X; Cheung AKL; Moog C; Xia H; Li Z; Wang R; Ji Y; Xia W; Liu Z; Yuan L; Wang X; Wu H; Zhang T; Su B
Front Immunol; 2022; 13():837921. PubMed ID: 35222430
[TBL] [Abstract][Full Text] [Related]
36. RHOA G17V Induces T Follicular Helper Cell Specification and Promotes Lymphomagenesis.
Cortes JR; Ambesi-Impiombato A; Couronné L; Quinn SA; Kim CS; da Silva Almeida AC; West Z; Belver L; Martin MS; Scourzic L; Bhagat G; Bernard OA; Ferrando AA; Palomero T
Cancer Cell; 2018 Feb; 33(2):259-273.e7. PubMed ID: 29398449
[TBL] [Abstract][Full Text] [Related]
37.
Ioannidou K; Ndiaye DR; Noto A; Fenwick C; Fortis SP; Pantaleo G; Petrovas C; de Leval L
Front Immunol; 2020; 11():607626. PubMed ID: 33633728
[TBL] [Abstract][Full Text] [Related]
38. Increased numbers of circulating ICOS⁺ follicular helper T and CD38⁺ plasma cells in patients with newly diagnosed primary biliary cirrhosis.
Wang L; Sun X; Qiu J; Cai Y; Ma L; Zhao P; Jiang Y
Dig Dis Sci; 2015 Feb; 60(2):405-13. PubMed ID: 25404409
[TBL] [Abstract][Full Text] [Related]
39. Expression of CXCL13 by neoplastic cells in angioimmunoblastic T-cell lymphoma (AITL): a new diagnostic marker providing evidence that AITL derives from follicular helper T cells.
Dupuis J; Boye K; Martin N; Copie-Bergman C; Plonquet A; Fabiani B; Baglin AC; Haioun C; Delfau-Larue MH; Gaulard P
Am J Surg Pathol; 2006 Apr; 30(4):490-4. PubMed ID: 16625095
[TBL] [Abstract][Full Text] [Related]
40. Comprehensive analysis of clinical, pathological, and genomic characteristics of follicular helper T-cell derived lymphomas.
Yoon SE; Cho J; Kim YJ; Ko YH; Park WY; Kim SJ; Kim WS
Exp Hematol Oncol; 2021 May; 10(1):33. PubMed ID: 33990228
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
